RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy (STREAM)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 11 Feb 2018
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Myocardial infarction; Unstable angina pectoris
- Focus Therapeutic Use
- Acronyms STREAM
- Sponsors AstraZeneca
- 20 Feb 2017 Planned End Date changed from 1 Jun 2018 to 1 Jul 2018.
- 20 Feb 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jul 2018.
- 03 Aug 2016 Status changed from recruiting to active, no longer recruiting.